Results 31 to 40 of about 22,234 (251)

Vaccination in emergencies. [PDF]

, 1999
Nongovernmental organisations (NGOs) are the main actors of vaccine delivery during complex humanitarian emergencies such as large population displacements.
Paquet, C
core   +2 more sources

Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya [PDF]

, 2017
Determinants of anticipated acceptance of an oral cholera vaccine (OCV) were studied in urban and rural communities of Western Kenya. An explanatory model interview administered to 379 community residents assessed anticipated vaccine acceptance at ...
CHAIGNAT, C.-L, HUTUBESSY, R., MBONGA, L. A., NYAMBEDHA, E. O., SCHAETTI, C., SUNDARAM, N., WEISS, M. G.   +6 more
core   +2 more sources

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study

The Lancet Global Health, 2016
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2–4 weeks between doses.
Dr. Andrew S Azman, PhD, Lucy A Parker, PhD, John Rumunu, MPH, Fisseha Tadesse, MPH, Francesco Grandesso, MPH, Lul L Deng, MD, Richard Laku Lino, MPH, Bior K Bior, PhD, Michael Lasuba, MS, Anne-Laure Page, PhD, Lameck Ontweka, BS, Augusto E Llosa, PhD, Sandra Cohuet, MD, Lorenzo Pezzoli, PhD, Dossou Vincent Sodjinou, MD, Abdinasir Abubakar, MD, Amanda K Debes, PhD, Allan M Mpairwe, MPH, Joseph F Wamala, MPH, Christine Jamet, MPH, Justin Lessler, PhD, Prof. David A Sack, MD, Marie-Laure Quilici, PhD, Iza Ciglenecki, MD, Francisco J Luquero, PhD   +24 more
doaj   +1 more source

Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults. [PDF]

PLoS Neglected Tropical Diseases, 2016
BACKGROUND:The bivalent whole-cell (BivWC) oral cholera vaccine (Shanchol) is effective in preventing cholera. However, evaluations of immune responses following vaccination with BivWC have been limited.
Wilfredo R Matias, Brie Falkard, Richelle C Charles, Leslie M Mayo-Smith, Jessica E Teng, Peng Xu, Pavol Kováč, Edward T Ryan, Firdausi Qadri, Molly F Franke, Louise C Ivers, Jason B Harris   +11 more
doaj   +1 more source

Modeling the Influence of Environment and Intervention on Cholera in Haiti [PDF]

, 2014
We propose a simple model with two infective classes in order to model the cholera epidemic in Haiti. We include the impact of environmental events (rainfall, temperature and tidal range) on the epidemic in the Artibonite and Ouest regions by introducing
Freitag, Caroline, Roudenko, Svetlana, Tennenbaum, Stephen   +2 more
core   +4 more sources

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. [PDF]

PLoS ONE, 2008
An effective vaccine against cholera has been used for public health purposes in Vietnam since the 1990s. This vaccine was reformulated to meet WHO requirements.
Dilip Mahalanabis, Anna Lena Lopez, Dipika Sur, Jacqueline Deen, Byomkesh Manna, Suman Kanungo, Lorenz von Seidlein, Rodney Carbis, Seung Hyun Han, Seong Hye Shin, Stephen Attridge, Raman Rao, Jan Holmgren, John Clemens, Sujit K Bhattacharya   +14 more
doaj   +1 more source

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines

Vaccines, 2021
Oral vaccination has the potential to offer a safer and more efficacious approach for protection against enteric pathogens than injection-based approaches, especially in developing countries. One key advantage is the potential to induce intestinal immune
Aqel Albutti, Stephanie Longet, Craig P. McEntee, Shauna Quinn, Alex Liddicoat, Cristiana Rîmniceanu, Nils Lycke, Lydia Lynch, Susanna Cardell, Ed C. Lavelle   +9 more
doaj   +1 more source

Live attenuated oral cholera vaccines

Expert Review of Vaccines, 2006
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. A single oral inoculation could result in intestinal colonization and rapid immune responses, obviating the need for repetitive dosing. Live V.
Edward T, Ryan, Stephen B, Calderwood, Firdausi, Qadri   +2 more
openaire   +2 more sources

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea (Review) [PDF]

, 2013
Background Infection with enterotoxigenic Escherichia coli (ETEC) bacteria is a common cause of diarrhoea in adults and children in developing countries and is a major cause of 'travellers' diarrhoea' in people visiting or returning from endemic regions.
Ahmed, Tanvir, Bhuiyan, Taufiqur, Quadri, Firdausi, Sinclair, David, Zaman, K   +4 more
core   +3 more sources

Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults. [PDF]

PLoS Neglected Tropical Diseases, 2019
The bivalent killed whole-cell oral cholera vaccine (BivWC) is being increasingly used to prevent cholera. The presence of O-antigen-specific memory B cells (MBC) has been associated with protective immunity against cholera, yet MBC responses have not ...
Brie Falkard, Richelle C Charles, Wilfredo R Matias, Leslie M Mayo-Smith, J Gregory Jerome, Evan S Offord, Peng Xu, Pavol Kováč, Edward T Ryan, Firdausi Qadri, Molly F Franke, Louise C Ivers, Jason B Harris   +12 more
doaj   +1 more source